Inactive Instrument

News Galapagos NV Euronext Bruxelles

Equities

GLPG

BE0003818359

Summary

Unlock all the news: Be the first to know and act before the market!

Frontier Medicines Corporation announced that it has received $99.999997 million in funding from a group of investors	Jun. 24	CI
Galapagos : Galapagos presents encouraging new data for CD19 CAR T candidate GLPG5101 in non Hodgkin lymphoma at EHA 2024	Jun. 17	PU
Galapagos Plans to Present 'Encouraging' Results for GLPG5101 in Non-Hodgkin Lymphoma	Jun. 14	MT
Galapagos : presents encouraging new data for CD19 CAR T candidate GLPG5101 in non Hodgkin lymphoma at EHA 2024	Jun. 14	PU
Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024	Jun. 14	GL
Galapagos NV Presents Encouraging New Data for CD19 CAR-T Candidate GLPG5101 in Non-Hodgkin Lymphoma at EHA 2024	Jun. 14	CI
Galapagos, Adaptimmune to Jointly Develop Head, Neck Cancer Treatment	May. 31	MT
Galapagos, Adaptimmune Therapeutics Team Up to Evaluate Head and Neck Cancer Drug	May. 31	MT
Galapagos : Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively license Adaptimmune’s TCR T cell therapy candidate, uza cel, in head & neck cancer and potential future so	May. 31	PU
Galapagos and Adaptimmune Sign Clinical Collaboration Agreement with an Option to Exclusively License Adaptimmune's TCR T-Cell Therapy Candidate, uza-cel	May. 30	CI
Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively license Adaptimmune’s TCR T-cell therapy candidate, uza-cel, in head & neck cancer and potential future solid tumor indications	May. 30	GL
Galapagos : Galapagos creates new subscription right plans	May. 17	PU
Galapagos creates new subscription right plans	May. 16	GL
Galapagos Partners with Blood Centers of America to Decentralize CAR-T Cell Therapy Manufacture	May. 16	MT
Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S.	May. 15	GL
Galapagos and Blood Centers of America Announce Strategic Collaboration to Accelerate Galapagos? Decentralized Car-T Manufacturing Network in the U.S	May. 15	CI
Transcript : Galapagos NV, Q1 2024 Earnings Call, May 03, 2024	May. 03
Galapagos : Galapagos reports first quarter 2024 financial results	May. 03	PU
Galapagos reports first quarter 2024 financial results	May. 02	GL
Galapagos NV Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Galapagos NV Euronext Bruxelles

Equities

GLPG

BE0003818359

Summary

Filters